Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

2.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
2.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

1.8K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.8K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

1.8K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.8K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

2.4K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.4K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

2.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The mouse Mid1 gene: implications for the pathogenesis of Opitz syndrome and the evolution of the mammalian pseudoautosomal region.

Human molecular genetics·1998
Same author

The TAATGARAT motif in the herpes simplex virus immediate-early gene promoters can confer both positive and negative responses to cellular octamer-binding proteins when it is located within the viral genome.

Journal of virology·1998
Same author

Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.

Biochemistry·1998
Same author

Delegation competencies. Beginning practitioners' reflections.

Nurse educator·1998
Same author

Use of the Comet assay to investigate the role of superoxide in glutathione-induced DNA damage.

Biochemical and biophysical research communications·1998
Same author

A guide to dressing selection.

Journal of wound care·1998
Same journal

Continuous integral debridement: optimising wound bed preparation through the cleanse, debride, cleanse and dress cycle.

Journal of wound care·2026
Same journal

Comprehensive management of lymphorrhoea: clinical implications, assessment and the role of superabsorbent dressings.

Journal of wound care·2026
Same journal

Foreword.

Journal of wound care·2026
Same journal

Managing high exudate in large leg ulcers: a case series.

Journal of wound care·2026
Same journal

Efficacy of insulin application in skin wound healing: a systematic review and meta-analysis.

Journal of wound care·2026
Same journal

Treating an unresponsive diabetic foot ulcer with cold atmospheric plasma, maggot therapy and alginate dressing: a case report.

Journal of wound care·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Generation of Alginate Microspheres for Biomedical Applications
10:33

Generation of Alginate Microspheres for Biomedical Applications

Published on: August 12, 2012

22.0K

Alginates.

S Thomas1

  • 1Director, Surgical Materials Testing Laboratory, Bridgend General Hospital, Bridgend, Mid Glamorgan.

Journal of Wound Care
|December 3, 2016
PubMed
Summary
This summary is machine-generated.

This guide explores alginate dressings, detailing their properties and applications. Learn about different types of alginate wound care solutions for optimal patient outcomes.

More Related Videos

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel
10:20

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel

Published on: June 29, 2017

20.7K
Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres
07:24

Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres

Published on: June 7, 2024

3.2K

Related Experiment Videos

Last Updated: Mar 11, 2026

Generation of Alginate Microspheres for Biomedical Applications
10:33

Generation of Alginate Microspheres for Biomedical Applications

Published on: August 12, 2012

22.0K
Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel
10:20

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel

Published on: June 29, 2017

20.7K
Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres
07:24

Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres

Published on: June 7, 2024

3.2K

Area of Science:

  • Biomaterials Science
  • Wound Care Management
  • Medical Device Technology

Background:

  • Alginate dressings are widely used in wound care due to their unique properties.
  • Understanding the variations in alginate dressings is crucial for effective clinical application.
  • The demand for advanced wound healing solutions necessitates a clear overview of available technologies.

Purpose of the Study:

  • To provide a comprehensive overview of the properties of various alginate dressings.
  • To outline the diverse clinical uses and applications of different alginate dressing formulations.
  • To serve as a practical guide for healthcare professionals selecting alginate dressings.

Main Methods:

  • Literature review of alginate dressing properties and clinical studies.
  • Analysis of manufacturer data on alginate dressing composition and performance.
  • Synthesis of information on indications, contraindications, and application techniques.

Main Results:

  • Detailed comparison of alginate dressings based on ionic composition (calcium, sodium).
  • Classification of dressings by form (sheets, ropes, pastes, gels).
  • Summary of efficacy in managing various wound types (exudative, deep, infected).

Conclusions:

  • Alginate dressings offer versatile wound management options.
  • Selection should be based on wound characteristics and desired outcomes.
  • Further research can optimize alginate dressing formulations for specific clinical needs.